Skip to main content Accessibility help
×
Home
  • Print publication year: 2009
  • Online publication date: July 2009

22 - CADASIL: a genetic model of arteriolar degeneration, white matter injury and dementia in later life

Summary

Introduction

Cerebral microvascular disease, as seen on magnetic resonance imaging (MRI) is common in the elderly (de Leeuw et al.,2000) and there is growing evidence that it makes a major contribution to cognitive impairment and dementia in the elderly, especially in the presence of fibrillar amyloid and tau pathology (Bennett et al., 1992, 1994; Snowdon, 1997; Snowdon et al., 2000; White et al., 2002) Understanding the unique impact of cerebral microvascular disease on cognition in the elderly is challenging because the base rate of Alzheimer's disease (AD) is high in this age group (Alzheimer's Association, 2007) making it difficult to reliably exclude patients with concomitant AD (Jellinger, 2002).

The CADASIL syndrome (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy) provides a valuable model for studying the pathogenesis of microvascular disease and the specific impact of subcortical vascular white matter injury on cognitive function. CADASIL is a genetic disorder characterized by progression of subcortical arteriolar degeneration and white matter lesions, with the development of white matter changes and clinical symptoms in early to mid adulthood, well before the onset of significant Alzheimer's pathology. Subcortical vascular dementia occurs in later stages of the illness, with a general correspondence between the severity of white matter lesions on MRI and the extent of cognitive deficits (Amberla et al., 2004). Moreover, the cognitive profile of CADASIL overlaps considerably with that of sporadic ischemic vascular disease in the elderly but differs from that of patients with AD (Charlton et al., 2006).

References
Agostoni, E. and Rigamonti, A. (2007) Migraine and cerebrovascular disease. Neurol Sci, 28(Suppl 2), S156–60.
,Alzheimer's Association (2007) Alzheimer's Disease Facts and Figures. Chicago, IL: Alzheimer's Association.
Amberla, K., Waljas, M., Tuominen, S.et al. (2004) Insidious cognitive decline in CADASIL. Stroke, 35, 1598–602.
Arboleda-Velasquez, J. F., Lopera, F., Lopez, E.et al. (2002) C455R Notch3 mutation in a Colombian CADASIL kindred with early onset of stroke. Neurology, 59, 277–9.
Arboleda-Velasquez, J. F., Rampal, R., Fung, E.et al. (2005) CADASIL mutations impair Notch3 glycosylation by Fringe. Hum Mol Genet, 14, 1631–9.
Atwood, L. D., Wolf, P. A., Heard-Costa, N. L.et al. (2004) Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke, 35, 1609–13.
Auer, D. P., Putz, B., Gossl, C.et al. (2001) Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology, 218, 443–51.
Barber, R., Gholkar, A., Scheltens, P.et al. (1999) Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias. Arch Neurol, 56, 961–5.
Baron, M. (2003) An overview of the Notch signalling pathway. Semin Cell Dev Biol, 14, 113–19.
Bennett, D. A., Gilley, D. W., Wilson, R. S., Huckman, M. S. and Fox, J. H. (1992) Clinical correlates of high signal lesions on magnetic resonance imaging in Alzheimer's disease. J Neurol, 239, 186–90.
Bennett, D. A., Gilley, D. W., Lee, S. and Cochran, E. J. (1994) White matter changes: neurobehavioral manifestations of Binswanger's disease and clinical correlates in Alzheimer's disease. Dementia, 5, 148–52.
Bianchi, S., Dotti, M. T. and Federico, A. (2006) Physiology and pathology of notch signalling system. J Cell Physiol, 207, 300–8.
Bousser, M. and Tournier-Lasserve, E. (2001) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: from stroke to vessel wall physiology. J Neurol Neurosurg Psychiatry, 70, 285–7.
Brennan-Krohn, T., Dong, M., Rivera, E., Salloway, S. and Monte, S. (2007) CADASIL: molecular analysis of aberrant gene expression in the brain. In Annual Meeting of the American Academy of Neurology, abstract PO7.119.
Bronge, L., Fernaeus, S., Blomberg, M.et al. (1999) White matter lesions in Alzheimer patients are influenced by apoliprotein E genotype. Dement Geriatr Cogn Disord, 10, 89–96.
Brulin, P., Godfraind, C., Leteurtre, E. and Ruchoux, M. M. (2002) Morphometric analysis of ultrastructural vascular changes in CADASIL: analysis of 50 skin biopsy specimens and pathogenic implications. Acta Neuropathol (Berl), 104, 241–8.
Carmelli, D., Decarli, C., Swan, G. E.et al. (1998) Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke, 29, 1177–81.
Carrera, P., Stenirri, S., Ferrari, M. and Battistini, S. (2001) Familial hemiplegic migraine: a ion channel disorder. Brain Res Bull, 56, 239–41.
Chabriat, H., Bousser, M. G. and Pappata, S. (1995) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a positron emission tomography study in two affected family members. Stroke, 26, 1729–30.
Chabriat, H., Levy, C., Taillia, H.et al. (1998) Patterns of MRI lesions in CADASIL. Neurology, 51, 452–7.
Chabriat, H., Mrissa, R., Levy, C.et al. (1999a) Brain stem MRI signal abnormalities in CADASIL. Stroke, 30, 457–9.
Chabriat, H., Pappata, S., Poupon, C.et al. (1999b) Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke, 30, 2637–43.
Charlton, R. A., Morris, R. G., Nitkunan, A. and Markus, H. S. (2006) The cognitive profiles of CADASIL and sporadic small vessel disease. Neurology, 66, 1523–6.
Choi, J. C., Kang, S. Y., Kang, J. H. and Park, J. K. (2006) Intracerebral hemorrhages in CADASIL. Neurology, 67, 2042–4.
Correia, S., Lee, S. Y., Voorn, T.et al. (2008) Quantitative tractography metrics of white matter integrity in diffusion-tensor MRI. Neuroimage, 42, 568–81.
Davous, P. (1998) Cadasil: a review with proposed diagnostic criteria. Eur J Neurol, 5, 219–33.
Leeuw, F. E., Groot, J. C. and Breteler, M. M. B. (2000) White matter changes: frequency and risk factors. In Pantoni, L., Intzitari, D. and Wallin, A. (eds.) The Matter of White Matter: Clinical and Pathophysiological Aspects of White Matter Disease Related to Cognitive Decline and Vascular Dementia. Utrecht: Academic Pharmaceutical Productions, pp. 19–33.
Leeuw, F. E., Richard, F., Groot, J. C.et al. (2004) Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke, 35, 1057–60.
Desmond, D. W. (2004) The neuropsychology of vascular cognitive impairment: is there a specific cognitive deficit? J Neurol Sci, 226, 3–7.
Desmond, D. W., Moroney, J. T., Lynch, T.et al. (1999) The natural history of CADASIL: a pooled analysis of previously published cases. Stroke, 30, 1230–3.
Dichgans, M. (2002) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: phenotypic and mutational spectrum. J Neurol Sci, 203–204, 77–80.
Dichgans, M., Mayer, M., Uttner, I.et al. (1998) The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol, 44, 731–9.
Dichgans, M., Filippi, M., Bruning, R.et al. (1999) Quantitative MRI in CADASIL: correlation with disability and cognitive performance. Neurology, 52, 1361–7.
Dichgans, M., Ludwig, H., Muller-Hocker, J., Messerschmidt, A. and Gasser, T. (2000) Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3 EGF-like repeat domains. Eur J Hum Genet, 8, 280–5.
Dichgans, M., Markus, H., Salloway, S.et al. (2008) Donepezil in patients with subcortical vascular impairment: a randomized, double-blind trial in CADASIL. Lancet Neurol, 7, 310–18.
Donahue, C. P. and Kosik, K. S. (2004) Distribution pattern of Notch3 mutations suggests a gain-of-function mechanism for CADASIL. Genomics, 83, 59–65.
Dong, Y., Hassan, A., Zhang, Z.et al. (2003) Yield of screening for CADASIL mutations in lacunar stroke and leukoaraiosis. Stroke, 34, 203–5.
Dubroca, C., Lacombe, P., Domenga, V.et al. (2005) Impaired vascular mechanotransduction in a transgenic mouse model of CADASIL arteriopathy. Stroke, 36, 113–17.
Fein, G., Di Sclafani, V., Tanabe, J.et al. (2000) Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology, 55, 1626–35.
Filippi, M. and Grossman, R. I. (2002) MRI techniques to monitor MS evolution: the present and the future. Neurology, 58, 1147–53.
Gunning-Dixon, F. M. and Raz, N. (2003) Neuroanatomical correlates of selected executive functions in middle-aged and older adults: a prospective MRI study. Neuropsychologia, 41, 1929–41.
Haritunians, T., Boulter, J., Hicks, C.et al. (2002) CADASIL Notch3 mutant proteins localize to the cell surface and bind ligand. Circ Res, 90, 506–8.
Haritunians, T., Chow, T., Lange, R. P.et al. (2005) Functional analysis of a recurrent missense mutation in Notch3 in CADASIL. J Neurol Neurosurg Psychiatry, 76, 1242–8.
Holtmannspotter, M., Peters, N., Opherk, C.et al. (2005) Diffusion magnetic resonance histograms as a surrogate marker and predictor of disease progression in CADASIL: a two-year follow-up study. Stroke, 36, 2559–65.
Jellinger, K. A. (2002) The pathology of ischemic-vascular dementia: an update. J Neurol Sci, 203–204, 153–7.
Joutel, A., Bousser, M. G., Biousse, V.et al. (1993) A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet, 5, 40–5.
Joutel, A., Corpechot, C., Ducros, A.et al. (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature, 383, 707–10.
Joutel, A., Andreux, F., Gaulis, S.et al. (2000) The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest, 105, 597–605.
Joutel, A., Monet, M., Domenga, V., Riant, F. and Tournier-Lasserve, E. (2004) Pathogenic mutations associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy differently affect Jagged1 binding and Notch3 activity via the RBP/JK signaling pathway. Am J Hum Genet, 74, 338–47.
Karlström, H., Beatus, P., Dannaeus, K.et al. (2002) A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling. Proc Natl Acad Sci USA, 99, 17119–24.
Koga, S. J., Hodges, M., Markin, C. and Gorman, P. (1995) MELAS syndrome. West J Med, 163, 379–81.
Lacombe, P., Oligo, C., Domenga, V., Tournier-Lasserve, E. and Joutel, A. (2005) Impaired cerebral vasoreactivity in a transgenic mouse model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy arteriopathy. Stroke, 36, 1053–8.
Lagas, P. A. and Juvonen, V. (2001) Schizophrenia in a patient with cerebral autosomally dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL disease). Nord J Psychiatry, 55, 41–2.
Leblanc, G. G., Meschia, J. F., Stuss, D. T. and Hachinski, V. (2006) Genetics of vascular cognitive impairment: the opportunity and the challenges. Stroke, 37, 248–55.
Lesnik Oberstein, S. A., Boom, R., Buchem, M. A.et al. (2001) Cerebral microbleeds in CADASIL. Neurology, 57, 1066–70.
Leyhe, T., Wiendl, H., Buchkremer, G. and Wormstall, H. (2005) CADASIL: underdiagnosed in psychiatric patients?Acta Psychiatr Scand, 111, 392–6; discussion 396–7.
Liem, M. K., Grond, J., Haan, J.et al. (2007) Lacunar infarcts are the main correlate with cognitive dysfunction in CADASIL. Stroke, 38, 923–8.
Louvi, A., Arboleda-Velasquez, J. F. and Artavanis-Tsakonas, S. (2006) CADASIL: a critical look at a Notch disease. Dev Neurosci, 28, 5–12.
Lundkvist, J., Zhu, S., Hansson, E. M.et al. (2005) Mice carrying a R142C Notch 3 knock-in mutation do not develop a CADASIL-like phenotype. Genesis, 41, 13–22.
Maclean, A. V., Woods, R., Alderson, L. M.et al. (2005) Spontaneous lobar haemorrhage in CADASIL. J Neurol Neurosurg Psychiatry, 76, 456–7.
Malloy, P., Correia, S., Stebbins, G. and Laidlaw, D. H. (2007) Neuroimaging of white matter in aging and dementia. Clin Neuropsychol, 21, 73–109.
Markus, H. S., Martin, R. J., Simpson, M. A.et al. (2002) Diagnostic strategies in CADASIL. Neurology, 59, 1134–8.
Mazzei, R., Conforti, F. L., Lanza, P. L.et al. (2004) A novel Notch3 gene mutation not involving a cysteine residue in an Italian family with CADASIL. Neurology, 63, 561–4.
Molko, N., Pappata, S., Mangin, J. F.et al. (2001) Diffusion tensor imaging study of subcortical gray matter in cadasil. Stroke, 32, 2049–54.
Molko, N., Cohen, L., Mangin, J. F.et al. (2002) Visualizing the neural bases of a disconnection syndrome with diffusion tensor imaging. J Cogn Neurosci, 14, 629–36.
Moseley, M. (2002) Diffusion tensor imaging and aging: a review. NMR Biomed, 15, 553–60.
O'Riordan, S., Nor, A. M. and Hutchinson, M. (2002) CADASIL imitating multiple sclerosis: the importance of MRI markers. Mult Scler, 8, 430–2.
O'Sullivan, M., Jones, D. K., Summers, P. E.et al. (2001) Evidence for cortical “disconnection” as a mechanism of age-related cognitive decline. Neurology, 57, 632–8.
O'Sullivan, M., Morris, R. G., Huckstep, B.et al. (2004) Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry, 75, 441–7.
O'Sullivan, M., Barrick, T. R., Morris, R. G., Clark, C. A. and Markus, H. S. (2005) Damage within a network of white matter regions underlies executive dysfunction in CADASIL. Neurology, 65, 1584–90.
O'Sullivan, M., Ngo, E., Viswanathan, A.et al. (2007) Hippocampal volume is an independent predictor of cognitive performance in CADASIL. Neurobiol Aging, e-pub ahead of print.
Okeda, R., Arima, K. and Kawai, M. (2002) Arterial changes in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) in relation to pathogenesis of diffuse myelin loss of cerebral white matter: examination of cerebral medullary arteries by reconstruction of serial sections of an autopsy case. Stroke, 33, 2565–9.
Opherk, C., Peters, N., Herzog, J., Luedtke, R. and Dichgans, M. (2004) Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. Brain, 127: 2533–9.
Opherk, C., Peters, N., Holtmannspotter, M.et al. (2006) Heritability of MRI lesion volume in CADASIL: evidence for genetic modifiers. Stroke, 37, 2684–9.
Patel, K., Correia, S., Foley, J.et al. (2007) Cognitive impairment, hippocampal volume, and white matter integrity in CADASIL. In 35th Annual Meeting of the International Neuropsychological Society, abstract 95.
Peters, N., Herzog, J., Opherk, C. and Dichgans, M. (2004a) A two-year clinical follow-up study in 80 CADASIL subjects: progression patterns and implications for clinical trials. Stroke, 35, 1603–8.
Peters, N., Opherk, C., Zacherle, S.et al. (2004b) CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk. Exp Cell Res, 299, 454–64.
Peters, N., Opherk, C., Danek, A.et al. (2005) The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia. Am J Psychiatry, 162, 2078–85.
Peters, N., Holtmannspotter, M., Opherk, C.et al. (2006) Brain volume changes in CADASIL: a serial MRI study in pure subcortical ischemic vascular disease. Neurology, 66, 1517–22.
Prakash, N., Hansson, E., Betsholtz, C., Mitsiadis, T. and Lendahl, U. (2002) Mouse Notch 3 expression in the pre- and postnatal brain: relationship to the stroke and dementia syndrome CADASIL. Exp Cell Res, 278, 31–44.
Roman, G. C. (1987) Senile dementia of the Binswanger type. A vascular form of dementia in the elderly. JAMA, 258, 1782–8.
Ruchoux, M. M. and Maurage, C. A. (1998) Endothelial changes in muscle and skin biopsies in patients with CADASIL. Neuropathol Appl Neurobiol, 24, 60–5.
Ruchoux, M. M., Domenga, V., Brulin, P.et al. (2003) Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol, 162, 329–42.
Salloway, S. and Desbiens, S. (2004) CADASIL and other genetic causes of stroke and vascular dementia. In Paul, R., Cohen, R., Ott, B. and Salloway, S. (eds.) Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management. Totowa, NJ, Humana Press, pp. 87–98.
Sawada, H., Udaka, F., Izumi, Y.et al. (2000) Cerebral white matter lesions are not associated with ApoE genotype but with age and female sex in Alzheimer's disease. J Neurol Neurosurg Psychiatry, 68, 653–6.
Scheid, R., Preul, C., Lincke, T.et al. (2006) Correlation of cognitive status, MRI- and SPECT-imaging in CADASIL patients. Eur J Neurol, 13, 363–70.
Schmidt, R., Schmidt, H., Fazekas, F.et al. (2000) MRI cerebral white matter lesions and paraoxonase PON1 polymorphisms: three-year follow-up of the Austrian stroke prevention study. Arterioscler Thromb Vasc Biol, 20, 1811–16.
Schulman, S. P., Becker, L. C., Kass, D. A.et al. (2006) l-Arginine therapy in acute myocardial infarction: the Vascular Interaction with Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA, 295, 58–64.
Shawber, C. J. and Kitajewski, J. (2004) Notch function in the vasculature: insights from zebrafish, mouse and man. Bioessays, 26, 225–34.
Sierra, C., Sierra, A., Mercader, J.et al. (2002) Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens, 20, 519–24.
Singhal, S., Bevan, S., Barrick, T., Rich, P. and Markus, H. S. (2004) The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain, 127, 2031–8.
Skoog, I. (1997) The relationship between blood pressure and dementia: a review. Biomed Pharmacother, 51, 367–75.
Snowdon, D. A. (1997) Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist, 37, 150–6.
Snowdon, D. A., Greiner, L. H. and Markesbery, W. R. (2000) Linguistic ability in early life and the neuropathology of Alzheimer's disease and cerebrovascular disease. Findings from the Nun Study. Ann N Y Acad Sci, 903, 34–8.
Taillia, H., Chabriat, H., Kurtz, A.et al. (1998) Cognitive alterations in non-demented CADASIL patients. Cerebrovasc Dis, 8, 97–101.
Thomas, N., Mathews, T. and Loganathan, A. (2002) Cadasil: presenting as a mood disorder. Scott Med J, 47, 36–7.
Trojano, M. and Paolicelli, D. (2001) The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes. Neurol Sci, 22(Suppl 2), S98–102.
Trojano, L., Ragno, M., Manca, A. and Caruso, G. (1998) A kindred affected by cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). A 2-year neuropsychological follow-up. J Neurol, 245, 217–22.
Turner, S. T., Jack, C. R., Fornage, M.et al. (2004) Heritability of leukoaraiosis in hypertensive sibships. Hypertension, 43, 483–7.
Vahedi, K., Chabriat, H., Levy, C.et al. (2004) Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol, 61, 1237–40.
Boom, R., Lesnik Oberstein, S. A., Duinen, S. G.et al. (2002) Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Radiology, 224, 791–6.
Boom, R., Lesnik Oberstein, S. A., Ferrari, M. D., Haan, J. and Buchem, M. A. (2003a) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging findings at different ages: 3rd–6th decades. Radiology, 229, 683–90.
Boom, R., Lesnik Oberstein, S. A., Spilt, A.et al. (2003b) Cerebral hemodynamics and white matter hyperintensities in CADASIL. J Cereb Blood Flow Metab, 23, 599–604.
Viswanathan, A., Gray, F., Bousser, M. G., Baudrimont, M. and Chabriat, H. (2006) Cortical neuronal apoptosis in CADASIL. Stroke, 37, 2690–5.
Weinmaster, G. (1997) The ins and outs of notch signaling. Mol Cell Neurosci, 9, 91–102.
Werbrouck, B. F. and Bleecker, J. L. (2006) Intracerebral haemorrhage in CADASIL. A case report. Acta Neurol Belg, 106, 219–21.
White, L., Petrovitch, H., Hardman, J.et al. (2002) Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci, 977, 9–23.
Willmot, M., Gray, L., Gibson, C., Murphy, S. and Bath, P. M. (2005) A systematic review of nitric oxide donors and l-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide, 12, 141–9.
Yousry, T. A., Seelos, K., Mayer, M.et al. (1999) Characteristic MR lesion pattern and correlation of T1 and T2 lesion volume with neurologic and neuropsychological findings in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Am J Neuroradiol, 20, 91–100.